A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT05031767` - Remote Monitoring of Axial Spondyloarthritis	N/A
Completed	`NCT05162937` - to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis	Phase 2
Completed	`NCT03622658` - Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis	Phase 2
Completed	`NCT03248518` - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases	N/A
Terminated	`NCT02437162` - A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis	Phase 3
Enrolling by invitation	`NCT06072859` - The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA)	N/A
Completed	`NCT02552212` - Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS	Phase 3
Active, not recruiting	`NCT01944163` - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain	N/A
Active, not recruiting	`NCT02687620` - Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
Completed	`NCT00844805` - Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)	Phase 3
Terminated	`NCT02897115` - A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment	Phase 4
Completed	`NCT05019547` - The Turkish Version of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity
Recruiting	`NCT03738956` - Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial	Phase 2/Phase 3
Completed	`NCT04679649` - Physiotherapy of Axial Spondyloarthritis	N/A
Enrolling by invitation	`NCT02962479` - Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis?	N/A
Completed	`NCT04485078` - Investigation of Central Sensitization Frequency and Related Factors in Axial Spondyloarthritis Patients
Recruiting	`NCT05812157` - Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17	N/A
Completed	`NCT03039088` - PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients
Completed	`NCT04368494` - Exercise Therapy in Patients With Axial Spondyloarthritis	N/A
Completed	`NCT03270501` - Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation	Phase 3

NCT number	NCT02354105
Study type	Observational
Source	UCB Pharma
Contact
Status	Completed
Phase
Start date	January 12, 2015
Completion date	March 9, 2018

A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life — CIMAX

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms